{"title":"S-Alkylated quinazolin-4(3H)-ones as dual EGFR/VEGFR-2 kinases inhibitors: design, synthesis, anticancer evaluation and docking study","link":"http://pubs.rsc.org/en/Content/ArticleLanding/2024/RA/D4RA04828H","date":null,"content":"<div><p><img src=\"/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D4RA04828H\" /></p></div><div><i><b>RSC Adv.</b></i>, 2024, <b>14</b>,26325-26339<br /><b>DOI</b>: 10.1039/D4RA04828H, Paper</div><div><img alt=\"Open Access\" src=\"http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/open_access_blue.png\" /> Open Access</div><div><a href=\"http://creativecommons.org/licenses/by-nc/3.0/\" target=\"_blank\"> <img src=\"http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/CCBY-NC.png\" alt=\"Creative Commons Licence\" /></a>  This article is licensed under a <a href=\"http://creativecommons.org/licenses/by-nc/3.0/\" target=\"_blank\">Creative Commons Attribution-NonCommercial 3.0 Unported Licence.</a></div><div>Samar S. Tawfik, Abdelrahman Hamdi, Ahmed R. Ali, Abdullah A. Elgazar, Hamed W. El-Shafey, Adel S. El-Azab, Ahmed H. Bakheit, Mohamed M. Hefnawy, Hazem A. Ghabbour, Alaa A.-M. Abdel-Aziz<br />Novel quinazolin-4(3<em>H</em>)-ones <strong>4–27</strong> were synthesized. Compounds <strong>4</strong>, <strong>11</strong>, and <strong>20</strong> showed potential anti-tumour activities. <strong>4</strong>, <strong>11</strong>, and <strong>20</strong> blocked EGFR/VEGFR-2 and triggered apoptosis. Compound <strong>4</strong> showed the most potent activity against EGFR/VEGFR-2.<br />The content of this RSS Feed (c) The Royal Society of Chemistry</div>","author":"","siteTitle":"RSC - RSC Adv. latest articles","siteHash":"da3e282678330308414c63a405ade89dd3738fcce2936ca8a2fe3a6d7e967d99","entryHash":"92cf914361eac9413be403c6f0af0967b02c3178833627c228d99e365f1ef95f","category":"Environment"}